Identification
Listing sponsor

Midcap Partners

Instrument name
SAFE ORTHOPAEDICS
Symbol
ALSAF
ISIN code
FR0012452746
Exchange / Market
Euronext Growth
Trading location
Paris
Products family
Stocks
ICB
Medical Equipment
Issuer website
www.safeorthopaedics.com
Operation
IPO date
IPO type

Direct Listing

IPO type
Transfer

Company profile

Safe Orthopaedics specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). Net sales break down by distribution channel as follows:
  • indirect sale (56%);
  • direct sale (44%): activity carried out in France, Germany and the United Kingdom.

Source: Cofisem - Last Update: 14 Aug 2020
Key Executives
Chairman and Chief Executive Officer Pierre Dumouchel
Administrative & Finance Director François-Henri Reynaud
Human Resources Director Nathalie Vazquez
Source: Cofisem - Last Update: 20 Jul 2020
Key figures
Millenium 2019 2018 2017 2016 2015
Net sales 4,792 3,471 3,110 2,365 2,498
Income from ordinary activities 4,792 3,471 3,110 2,385 2,532
Operating income -7,449 -6,150 -5,434 -6,287 -7,218
Cost of financial indebtedness net -23 -20 -37 2
Equity-accounted companies contribution to income
Net profit from discontinued activities
Net income -7,970 -5,800 -6,575 -6,005 -6,566
Net income (Group share) -5,800 -6,575 -6,005 -6,566
Fiscal year end 12.19 12.18 12.17 12.16 12.15
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 14 Aug 2020
Shareholder information
Ehgo Securitization Fund 30.60 %
Kurma Partners 2.30 %
Kurma Biofund 2.03 %
European High Growth Opportunities Manco 1.80 %
Kisco 1.37 %
IDinvest 1.23 %
TLP European Investment 0.94 %
Managers 0.48 %
Founders 0.43 %
Invistm SAS 0.38 %
Employees 0.21 %
Pierre Dumouchel 0.10 %
Group-owned stock 0.06 %
Source: Cofisem - Last Update: 14 Aug 2020